Cargando…
Immunotherapy: The future of cancer treatment
Head and neck squamous cell carcinomas (HNSCCs) are one of the most common cancers worldwide. A large number of patients are diagnosed with locally advanced disease and require multimodal treatment approaches. Standard treatment modalities ranging from surgery to chemotherapy and radiation are yield...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8491352/ https://www.ncbi.nlm.nih.gov/pubmed/34703141 http://dx.doi.org/10.4103/0973-029X.325257 |
_version_ | 1784578724057841664 |
---|---|
author | Sahu, Manisha Suryawanshi, Hemakumari |
author_facet | Sahu, Manisha Suryawanshi, Hemakumari |
author_sort | Sahu, Manisha |
collection | PubMed |
description | Head and neck squamous cell carcinomas (HNSCCs) are one of the most common cancers worldwide. A large number of patients are diagnosed with locally advanced disease and require multimodal treatment approaches. Standard treatment modalities ranging from surgery to chemotherapy and radiation are yielding mixed results. To overcome this hurdle, newer innovative approaches are required to reduce the morbidity and mortality of the patients. In the last few decades, immunotherapy has become an important part of treating some types of cancer. The immune system plays a key role in the development, establishment and progression of HNSCC. A greater understanding of the dysregulation and evasion of the immune system in the evolution and progression of HNSCC provides the basis for improved therapies and outcomes for patients. Newer types of immune treatments are now being studied, and they will impact how we treat cancer in the future. This article provides a brief overview of the current immunotherapeutic strategies for cancer with emphasis on HNSCC. |
format | Online Article Text |
id | pubmed-8491352 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Medknow Publications & Media Pvt Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-84913522021-10-25 Immunotherapy: The future of cancer treatment Sahu, Manisha Suryawanshi, Hemakumari J Oral Maxillofac Pathol Review Article Head and neck squamous cell carcinomas (HNSCCs) are one of the most common cancers worldwide. A large number of patients are diagnosed with locally advanced disease and require multimodal treatment approaches. Standard treatment modalities ranging from surgery to chemotherapy and radiation are yielding mixed results. To overcome this hurdle, newer innovative approaches are required to reduce the morbidity and mortality of the patients. In the last few decades, immunotherapy has become an important part of treating some types of cancer. The immune system plays a key role in the development, establishment and progression of HNSCC. A greater understanding of the dysregulation and evasion of the immune system in the evolution and progression of HNSCC provides the basis for improved therapies and outcomes for patients. Newer types of immune treatments are now being studied, and they will impact how we treat cancer in the future. This article provides a brief overview of the current immunotherapeutic strategies for cancer with emphasis on HNSCC. Medknow Publications & Media Pvt Ltd 2021 2021-08-31 /pmc/articles/PMC8491352/ /pubmed/34703141 http://dx.doi.org/10.4103/0973-029X.325257 Text en Copyright: © 2021 Journal of Oral and Maxillofacial Pathology https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. |
spellingShingle | Review Article Sahu, Manisha Suryawanshi, Hemakumari Immunotherapy: The future of cancer treatment |
title | Immunotherapy: The future of cancer treatment |
title_full | Immunotherapy: The future of cancer treatment |
title_fullStr | Immunotherapy: The future of cancer treatment |
title_full_unstemmed | Immunotherapy: The future of cancer treatment |
title_short | Immunotherapy: The future of cancer treatment |
title_sort | immunotherapy: the future of cancer treatment |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8491352/ https://www.ncbi.nlm.nih.gov/pubmed/34703141 http://dx.doi.org/10.4103/0973-029X.325257 |
work_keys_str_mv | AT sahumanisha immunotherapythefutureofcancertreatment AT suryawanshihemakumari immunotherapythefutureofcancertreatment |